PBE vs. MLI
PBE (Invesco Dynamic Biotechnology & Genome ETF) is Health & Biotech Equities fund tracking the Dynamic Biotech & Genome Intellidex Index (AMEX), while MLI (Mueller Industries, Inc.) is a stock. Over the past 10 years, PBE returned 8.90%/yr vs 26.81%/yr for MLI. At a 0.49 correlation, their price movements are largely independent.
Performance
PBE vs. MLI - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, PBE achieves a 3.32% return, which is significantly lower than MLI's 20.69% return. Over the past 10 years, PBE has underperformed MLI with an annualized return of 8.90%, while MLI has yielded a comparatively higher 26.81% annualized return.
PBE
- 1D
- 0.81%
- 1M
- 4.85%
- YTD
- 3.32%
- 6M
- 5.17%
- 1Y
- 34.13%
- 3Y*
- 10.91%
- 5Y*
- 2.31%
- 10Y*
- 8.90%
MLI
- 1D
- -0.25%
- 1M
- 1.23%
- YTD
- 20.69%
- 6M
- 20.88%
- 1Y
- 87.45%
- 3Y*
- 52.10%
- 5Y*
- 45.38%
- 10Y*
- 26.81%
PBE vs. MLI - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
PBE Invesco Dynamic Biotechnology & Genome ETF | 3.32% | 24.84% | 1.10% | 3.71% | -10.83% | 1.54% | 25.66% | 18.65% | -0.19% | 22.28% |
MLI Mueller Industries, Inc. | 20.69% | 46.29% | 70.51% | 62.38% | 1.05% | 70.95% | 12.30% | 37.79% | -33.10% | -2.76% |
Correlation
The correlation between PBE and MLI is 0.34, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.34 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.44 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.45 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.41 |
Correlation (All Time) Calculated using the full available price history since Jun 23, 2005 | 0.49 |
The correlation between PBE and MLI shifts across timeframes, from 0.34 (1 year) to 0.49 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PBE vs. MLI — Risk / Return Rank
PBE
MLI
PBE vs. MLI - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Invesco Dynamic Biotechnology & Genome ETF (PBE) and Mueller Industries, Inc. (MLI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| PBE | MLI | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.12 | ||
| Sortino ratioReturn per unit of downside risk | -0.76 | ||
| Omega ratioGain probability vs. loss probability | 1.31 | 1.50 | -0.20 |
| Calmar ratioReturn relative to maximum drawdown | 2.92 | 3.94 | -1.01 |
| Martin ratioReturn relative to average drawdown | 8.21 | 10.92 | -2.71 |
Loading charts...
Drawdowns
PBE vs. MLI - Drawdown Comparison
The maximum PBE drawdown since its inception was -45.69%, smaller than the maximum MLI drawdown of -61.72%. Use the drawdown chart below to compare losses from any high point for PBE and MLI.
Loading charts...
Drawdown Indicators
| PBE | MLI | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.69% | -61.72% | +16.03% |
Max Drawdown (1Y)Largest decline over 1 year | -11.73% | -22.33% | +10.60% |
Max Drawdown (3Y)Largest decline over 3 years | -22.43% | -27.79% | +5.36% |
Max Drawdown (5Y)Largest decline over 5 years | -34.71% | -27.79% | -6.92% |
Max Drawdown (10Y)Largest decline over 10 years | -37.84% | -52.95% | +15.11% |
Current DrawdownCurrent decline from peak | -1.00% | -1.93% | +0.93% |
Average DrawdownAverage peak-to-trough decline | -16.21% | -16.04% | -0.17% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.17% | 8.03% | -3.86% |
Volatility
PBE vs. MLI - Volatility Comparison
The current volatility for Invesco Dynamic Biotechnology & Genome ETF (PBE) is 6.04%, while Mueller Industries, Inc. (MLI) has a volatility of 10.51%. This indicates that PBE experiences smaller price fluctuations and is considered to be less risky than MLI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PBE | MLI | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | 10.51% | -4.47% |
Volatility (6M)Calculated over the trailing 6-month period | 13.67% | 25.79% | -12.12% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.01% | 30.06% | -11.05% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.48% | 33.07% | -10.59% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 24.91% | 35.79% | -10.88% |
Dividends
PBE vs. MLI - Dividend Comparison
PBE's dividend yield for the trailing twelve months is around 1.02%, more than MLI's 0.87% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MLI Mueller Industries, Inc. | 0.87% | 0.87% | 1.01% | 1.27% | 1.69% | 0.88% | 1.14% | 1.26% | 1.71% | 9.60% | 0.94% | 1.11% |
PBE Invesco Dynamic Biotechnology & Genome ETF | 1.02% | 1.00% | 0.05% | 0.02% | 0.00% | 0.00% | 0.04% | 0.00% | 0.00% | 0.57% | 0.38% | 1.12% |
Frequently Asked Questions
PBE and MLI have a correlation of 0.34, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MLI has higher volatility (10.51%) compared to PBE (6.04%). In terms of maximum drawdown, PBE dropped -45.69% vs MLI's -61.72%.
MLI currently has the higher Sharpe Ratio (2.93 vs 1.81), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for PBE and MLI
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer